Canada markets closed

Theralase Technologies Inc. (TLTFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1212-0.0030 (-2.42%)
At close: 02:52PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.1242
Open0.1250
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1207 - 0.1250
52 Week Range0.1100 - 0.2400
Volume47,570
Avg. Volume77,261
Market Cap28.498M
Beta (5Y Monthly)1.59
PE Ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings DateMay 28, 2024 - Jun 03, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement

    TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase® Technologies Inc. ("Theralase® " or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation ...

  • ACCESSWIRE

    Theralase(R) Granted Canadian Cancer Vaccine Patent

    TORONTO, ON / ACCESSWIRE / April 5, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated ...

  • ACCESSWIRE

    Theralase(R) Release's 4Q2023 Interim Financial Statements

    TORONTO, ON / ACCESSWIRE / March 27, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated ...